NEW YORK (GenomeWeb News) – Siemens Healthcare has agreed to a five-year supply, distribution, sales, and service contract with Japanese firm Sysmex, Siemens said today.

The global agreement will cover distribution of a variety of diagnostic tests and coagulation instruments to test and monitor patients using blood thinning medications, Siemens said. The agreement also includes access to automated platelet function testing.

The firms also intend to continue joint product development efforts related to coagulation technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.